ascorbic acid 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / lutein 5 MG / zinc oxide 34.8 MG Oral Capsule
RxNorm concept 891816, clinical drug (scd).
- RxCUI
- 891816
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/891816 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
vit-C 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / Lutein 5 MG / ZNO 34.8 MG Oral Capsule; vitamin C 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / Lutein 5 MG / ZNO 34.8 MG Oral Capsule
Related concepts
- lutein 5 MG (SCDC, consists of)
- ascorbic acid 226 MG (SCDC, consists of)
- cuprous oxide 0.8 MG (SCDC, consists of)
- dl-alpha tocopheryl acetate 200 UNT (SCDC, consists of)
- zinc oxide 34.8 MG (SCDC, consists of)
- Oral Capsule (DF, has dose form)
- ascorbic acid 226 MG / cuprous oxide 0.8 MG / dl-alpha tocopheryl acetate 200 UNT / lutein 5 MG / zinc oxide 34.8 MG Oral Capsule [PreserVision with Lutein] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 891816 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/891816 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 891816. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.